logo
Plus   Neg
Share
Email

Stella Artois Recalls Beer That May Contain Particles Of Glass

Stella Artois has recalled 11.2-ounce bottles of beer that may contain particles of glass.

The recall applies to Stella Artois 6-packs, 12-packs, 18-packs, 24-packs, "Best of Belgium" multi-packs in the U.S. and Canada, and Stella Artois Légère 6-packs and 12-packs in the U.S.

The company said the recall impacts less than 1% of Stella Artois glass bottles sold in North America annually, and affected bottles will be far less than this.

The recall comes after the detection of a glass packaging flaw in some 11.2-ounce bottles that may cause a small piece of glass to break off and possibly fall into the beer. The potentially-affected bottles were manufactured by a third-party.

"We made the decision to voluntarily recall certain packages potentially containing the affected 11.2-ounce (330ml) bottles as a precautionary measure to ensure the safety of our consumers," the company said in a statement.

"The safety of our consumers is our top priority. While the number of potentially-affected glass bottles is very small, we are recalling these Stella Artois packages as a precautionary measure," said Christina Choi, Global Brand VP, Stella Artois. "Our team of technical experts has been working with our third-party glass bottle supplier to ensure this packaging flaw has been addressed."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of Volkswagen Group were gaining around 3 percent in German trading after the automotive giant Thursday reported market recovery in the third quarter with improved deliveries in the month of September. For the first nine months of fiscal 2020, the company, meanwhile reported sharply lower earnings with weak revenues and sales volume. Comcast Corp. on Thursday reported a 37 percent decline in profit for the third quarter from last year, hurt primarily by revenue decline at NBCUniversal. Both adjusted earnings per share and quarterly revenues topped analysts' expectations. The company also declared a quarterly dividend. In the pre-market trade, CMCSA is trading at $42.83, up $0.85 or 2.02 percent. Regeneron announced positive results from its late stage COVID-19 outpatient trial, indicating that its antibody cocktail therapy significantly reduced virus levels and need for further medical attention. The trial results showed that investigational antibody cocktail, REGN-COV2, met the primary and key secondary endpoints.
RELATED NEWS
Follow RTT